Annapurna Swadisht Limited (NSE:ANNAPURNA)
284.10
+2.80 (1.00%)
At close: Aug 1, 2025
Verve Therapeutics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
Cash & Equivalents | 297.49 | 33.02 | 72.01 | 17.81 | 0.49 | Upgrade |
Cash & Short-Term Investments | 297.49 | 33.02 | 72.01 | 17.81 | 0.49 | Upgrade |
Cash Growth | 801.07% | -54.15% | 304.39% | 3519.31% | -36.19% | Upgrade |
Accounts Receivable | 582.38 | 293.64 | 198.35 | 62.59 | 9.59 | Upgrade |
Other Receivables | - | 0.53 | - | - | 4.42 | Upgrade |
Receivables | 905.96 | 327.38 | 198.35 | 62.59 | 14.01 | Upgrade |
Inventory | 759.54 | 577.61 | 293.9 | 80.89 | 24.17 | Upgrade |
Other Current Assets | 103.31 | 336.69 | 183.47 | 34.52 | 8.47 | Upgrade |
Total Current Assets | 2,066 | 1,275 | 747.72 | 195.81 | 47.15 | Upgrade |
Property, Plant & Equipment | 914.61 | 843.49 | 344.11 | 109.32 | 59.86 | Upgrade |
Long-Term Investments | 65.4 | 21.89 | - | - | 6.1 | Upgrade |
Goodwill | 1,383 | 122.11 | - | - | - | Upgrade |
Other Intangible Assets | 1.81 | 0.54 | 0.35 | - | - | Upgrade |
Other Long-Term Assets | - | 85.95 | 25.85 | 3.13 | 1.34 | Upgrade |
Total Assets | 4,695 | 2,362 | 1,118 | 308.26 | 114.45 | Upgrade |
Accounts Payable | 232.31 | 411.86 | 178.64 | 78.62 | 26.77 | Upgrade |
Accrued Expenses | - | 52.6 | 29.36 | 16.42 | 0.52 | Upgrade |
Short-Term Debt | 775.01 | 542.59 | 159.03 | 38.13 | 17.44 | Upgrade |
Current Portion of Long-Term Debt | - | 6.64 | 19.31 | 5.57 | 0.37 | Upgrade |
Current Income Taxes Payable | 58.16 | 44.27 | 24.17 | 10.26 | 2.82 | Upgrade |
Current Unearned Revenue | - | 20.47 | 9.46 | 30.72 | - | Upgrade |
Other Current Liabilities | 346.16 | 44.23 | 35.82 | 9.25 | 4.14 | Upgrade |
Total Current Liabilities | 1,412 | 1,123 | 455.78 | 188.96 | 52.06 | Upgrade |
Long-Term Debt | 223.56 | 83.46 | 62.73 | 34.74 | 39.27 | Upgrade |
Long-Term Deferred Tax Liabilities | 5.21 | 5.14 | 1.9 | 0.01 | - | Upgrade |
Other Long-Term Liabilities | 8.93 | 4.97 | - | 0 | - | Upgrade |
Total Liabilities | 1,649 | 1,216 | 520.4 | 223.72 | 91.33 | Upgrade |
Common Stock | 218.2 | 175.9 | 164.22 | 1 | 23.12 | Upgrade |
Additional Paid-In Capital | - | 689.31 | 356.43 | - | - | Upgrade |
Retained Earnings | - | 203.27 | 76.98 | 5.54 | - | Upgrade |
Comprehensive Income & Other | 2,781 | 77.44 | - | 78 | - | Upgrade |
Total Common Equity | 2,999 | 1,146 | 597.63 | 84.54 | 23.12 | Upgrade |
Minority Interest | 47.26 | - | - | - | - | Upgrade |
Shareholders' Equity | 3,046 | 1,146 | 597.63 | 84.54 | 23.12 | Upgrade |
Total Liabilities & Equity | 4,695 | 2,362 | 1,118 | 308.26 | 114.45 | Upgrade |
Total Debt | 998.57 | 632.68 | 241.06 | 78.44 | 57.08 | Upgrade |
Net Cash (Debt) | -701.08 | -599.67 | -169.06 | -60.63 | -56.59 | Upgrade |
Net Cash Per Share | -38.62 | -32.17 | -10.29 | -8.66 | -8.08 | Upgrade |
Filing Date Shares Outstanding | 14.48 | 18.19 | 16.42 | 12.1 | 7 | Upgrade |
Total Common Shares Outstanding | 14.48 | 17.59 | 16.42 | 0.1 | 7 | Upgrade |
Working Capital | 654.66 | 152.04 | 291.95 | 6.84 | -4.92 | Upgrade |
Book Value Per Share | 207.13 | 65.15 | 36.39 | 845.39 | 3.30 | Upgrade |
Tangible Book Value | 1,614 | 1,023 | 597.28 | 84.54 | 23.12 | Upgrade |
Tangible Book Value Per Share | 111.51 | 58.17 | 36.37 | 845.39 | 3.30 | Upgrade |
Land | - | 35.88 | - | - | - | Upgrade |
Buildings | - | 17.31 | - | 7.85 | 9.06 | Upgrade |
Machinery | - | 373.12 | - | 65.95 | 37.31 | Upgrade |
Construction In Progress | - | 217.22 | - | 16.48 | 18.01 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.